PHARMACEUTICAL COMPOSITION FOR A ATHEROSCLEROSIS,DYSLIPIDEMIAS AND RELATED CONDITIONS

摘要

A pharmaceutical composition for treatment of atherosclerosis, dyslipidemias and related conditions is disclosed wherein nicotinic acid is administered to the patient in combination with a DP receptor antagonist and HMG Co-A reductase inhibitor. The DP receptor antagonist is administered to reduce, prevent or eliminate flushing that may otherwise occur.